A Review of the Opioid Epidemic: What Do We Do About It?
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The opioid epidemic, with its noticeable increase in opioid prescriptions and related misuse, abuse and resultant deaths in the previous 12 years, is a particularly North American phenomenon. Europe, and particularly low- and middle-income countries, appear to be less influenced by this problem. There is undisputable value in using opioids not only in the treatment of acute pain, but in cancer pain as well. However, opioids are progressively being prescribed more and more for chronic non-cancer pain, despite inadequate data on their efficacy. In this paper, we describe the current prevalence of opioid misuse in a number of countries and the rationale for the commencement of opioid therapy. The safe initiation and monitoring of opioid therapy as well as the need for concurrent use of interdisciplinary multimodal therapy is discussed. The possible consequences of long-term use and predictors of high opioid use and overdose are presented. In particular, the management of opioid use disorders and the prevention of opioid abuse and dependence in the young, the old and the pregnant are discussed. Measures to prevent overprescribing and to alleviate risk are described, including the tapering of opioids and the use of opioid deterrents. Finally, the paper looks at the future development of pioneering medications and technologies to potentially treat abuse. In those parts of the world with an opioid epidemic, coroners and medical examiners, private and public health agencies, and agencies that enforce the law need to cooperate in an effort to slow down and reverse the indiscriminate use of prescribing opioids in the long-term for chronic non-cancer pain. Ongoing research is needed to create ways to minimise risks of opioid use, and to provide evidence for effective strategies for treating chronic pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980 · cited 1×
“Regarding age, opioid use should be limited in the elderly due to adverse effects (low numbers needed to harm or NNH), and restricted in children [25, 45].”
BackgroundChou, R., Gordon, D. B., de Leon-Casasola, O. A., Rosenberg, J. M., Bickler, S., Brennan, T., Carter, T., Cassidy, C. L., Chittenden, E. H., Degenhardt, E., et al. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2015.12.008 · Cited by 3,171
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Increases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859
Chou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I., Dana, T., Bougatsos, C., & Deyo, R. A. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2559 · Cited by 1,606
Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies
Fayaz, A., Croft, P., Langford, R. M., Donaldson, L. J., & Jones, G. T. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010364 · Cited by 1,355
Opioid Epidemic in the United States
Manchikanti, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es9 · Cited by 1,180
The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013
Florence, C. S., Zhou, C., Luo, F., & Xu, L. (2016) · Medical Care · doi:10.1097/mlr.0000000000000625 · Cited by 1,152
Shah, A., Hayes, C. J., & Martin, B. C. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6610a1 · Cited by 954 · cited 1×
“Most opioid abusers’ first exposure to opioids began with a lawful prescription for pain [38].”
Background
Cited by
Noble, F., & Marie, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00742 · Cited by 56
Glauser, G., Ali, Z. S., Gardiner, D., Ramayya, A. G., Pessoa, R., Grady, M. S., Welch, W. C., Zager, E. L., Sim, E., Haughey, V., et al. (2019) · mHealth · doi:10.21037/mhealth.2019.09.01 · Cited by 25
Syx, D., Miller, R. E., Obeidat, A. M., Tran, P. B., Vroman, R., Malfait, Z., Miller, R. J., Malfait, F., & Malfait, A.-M. (2020) · Pain · doi:10.1097/j.pain.0000000000001935 · Cited by 19
Kakko, J., Gedeon, C., Sandell, M., Grelz, H., Birkemose, I., Clausen, T., Rúnarsdóttir, V., Simojoki, K., Littlewood, R., Alho, H., et al. (2018) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-018-0160-7 · Cited by 10
“Illicit heroin is now not the only source of opioid and in some countries, is not the major problem: OA may make up a large proportion of the opioid problem whether prescribed, illicit or obtained from family or other contacts [16].”
Background
Metadata
- Authors
- Shipton, E. A., Shipton, E. E., & Shipton, A. J.
- Venue
- Pain and Therapy
- Published
- 2018-04-06
- Volume
- 7
- Issue
- 1
- Pages
- 23-36
- ISSN
- 2193-651X (ISSN-L)
- 2193-8237
- OpenAlex
- W2795835640
- Cited by
- 161
- References
- 15
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review of the Opioid Epidemic: What Do We Do About It? https://app.cochat.ai/papers/10.1007/s40122-018-0096-7
- The paper
- Shipton, E. A., Shipton, E. E., & Shipton, A. J. (2018). A Review of the Opioid Epidemic: What Do We Do About It? Pain and Therapy. https://doi.org/10.1007/s40122-018-0096-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.